# Microalgal therapeutic peptides: From biomass to bone tissue engineering

**Authors:** Diana Pacheco, Tatiana M.F. Patrício, Abílio J.F.N. Sobral, Telma Encarnação

PMC · DOI: 10.1016/j.mtbio.2026.102938 · Materials Today Bio · 2026-02-18

## TL;DR

This review explores how peptides from microalgae can be used to create safe and effective biomaterials for bone tissue engineering.

## Contribution

The paper provides a comprehensive overview of microalgae-derived peptides for bone regeneration, emphasizing sustainable and patient-specific approaches.

## Key findings

- Microalgae-derived peptides show high cellular compatibility and osteogenic activity.
- Advanced delivery systems enable 3D printing of patient-specific bone implants using microalgal peptides.
- Scalable production and regulatory strategies are critical for clinical translation of these peptides.

## Abstract

Bone tissue engineering continues to face challenges in developing biomaterials that are both safe and biologically active, particularly in promoting integration with native tissue. Traditional synthetic materials often lack cellular compatibility, driving research toward natural and biomimetic alternatives. In this context, microalgae have a diverse metabolic profile, producing several biologically active compounds (i.e. lipids, carbohydrates, pigments) with therapeutic potential for bone regeneration. Among these, peptides gain relevance due to their high cellular compatibility, osteogenic activity and tunable properties. Herein, this review provides a comprehensive and critical overview of microalgae-derived peptides, covering their manufacturing process. It covers the entire workflow from protein extraction to peptide purification and characterization. It summarizes their biological properties and therapeutic applications in bone regeneration and examines their status in clinical studies alongside the main regulatory and translational challenges. Particular focus will be given to the combination of advanced delivery systems for using microalgae therapeutic peptides to develop patient-specific implants. Overall, this review emphasizes the significance of microalgae as a versatile and sustainable resource to extract therapeutic peptides and to develop the next generation of biomaterials in bone regenerative medicine.

Image 1

•Microalgae are a sustainable source of peptides with biological activity.•Advances in extraction and characterization techniques enhance peptide quality and reproducibility.•Microalgal peptide-based hydrogels support 3D printing of patient-specific bone implants.•Scalable production and regulatory considerations are essential for clinical translation.•Microalgal peptides offer a promising platform for next-generation biomaterials in regenerative medicine.

Microalgae are a sustainable source of peptides with biological activity.

Advances in extraction and characterization techniques enhance peptide quality and reproducibility.

Microalgal peptide-based hydrogels support 3D printing of patient-specific bone implants.

Scalable production and regulatory considerations are essential for clinical translation.

Microalgal peptides offer a promising platform for next-generation biomaterials in regenerative medicine.

## Full-text entities

- **Genes:** ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, CAT (catalase) [NCBI Gene 847], NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** basophilic leukemia (MESH:D015471), cancer (MESH:D009369), liver fibrosis (MESH:D008103), osteosarcoma (MESH:D012516), inflammation (MESH:D007249), bone fractures (MESH:D050723), ICH (MESH:D000082122), Bacterial infections (MESH:D001424), infection (MESH:D007239), bone defects (MESH:D001847), cytotoxicity (MESH:D064420), osteoporosis (MESH:D010024)
- **Chemicals:** glutamic acid (MESH:D018698), asparagine (MESH:D001216), 13C (MESH:C000615229), hydroxyl radicals (MESH:D017665), amide (MESH:D000577), water (MESH:D014867), tyrosine (MESH:D014443), Peptide (MESH:D010455), histidine (MESH:D006639), isoleucine (MESH:D007532), DPPH (MESH:C004931), metal (MESH:D008670), methionine (MESH:D008715), histamine (MESH:D006632), proline (MESH:D011392), gold (MESH:D006046), acrylate (MESH:C036658), chitosan (MESH:D048271), aromatic amino acids (MESH:D024322), methacrylate (MESH:D008689), lysine (MESH:D008239), tryptophan (MESH:D014364), PU (MESH:D011140), HS (MESH:D006859), threonine (MESH:D013912), heavy metals (MESH:D019216), ROS (MESH:D017382), HO (MESH:D006695), lipid (MESH:D008055), cysteine (MESH:D003545), aspartic acid (MESH:D001224), polyvinyl alcohol (MESH:D011142), thiol (MESH:D013438), FHRRIKA (MESH:C546710), Amino acids (MESH:D000596), polycaprolactone (MESH:C016240), phenylalanine (MESH:D010649), serine (MESH:D012694), carbohydrates (MESH:D002241), 1H (-), superoxide (MESH:D013481), silica (MESH:D012822), RGD (MESH:C047981)
- **Species:** Nannochloropsis oculata (species) [taxon 43925], aureus [taxon 46170], Porphyridium purpureum (species) [taxon 35688], Aliivibrio fischeri (species) [taxon 668], Chlorella sp. (species) [taxon 3079], Chlorella vulgaris (species) [taxon 3077], Mus musculus (house mouse, species) [taxon 10090], Pavlova lutheri [taxon 2832], Arthrospira sp. (species) [taxon 35824], Limnospira platensis (species) [taxon 118562], Escherichia coli (E. coli, species) [taxon 562], Glycine max (soybean, species) [taxon 3847], Nannochloropsis sp. (species) [taxon 52230], Navicula salinicola (species) [taxon 63141], Gallus gallus (bantam, species) [taxon 9031], Spirulina sp. (species) [taxon 1157], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Chlorella sorokiniana (species) [taxon 3076], Auxenochlorella pyrenoidosa (species) [taxon 3078], Thalassiosira oceanica (species) [taxon 159749]
- **Cell lines:** HEK — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_M624), MG-63 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0426), RBL-2H3 — Rattus norvegicus (Rat), Rat leukemia, Cancer cell line (CVCL_0591), HFFF-2 — Homo sapiens (Human), Finite cell line (CVCL_2489), NIH-3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), EA.hy926 — Homo sapiens (Human), Hybrid cell line (CVCL_3901), D1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_RG58), SVEC4-10 — Mus musculus (Mouse), Transformed cell line (CVCL_4393)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950423/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950423/full.md

## References

120 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950423/full.md

---
Source: https://tomesphere.com/paper/PMC12950423